IQV

IQVIA HOLDINGS INC.
7 filings tracked
healthcarehealthcare it servicesLARGE ($10B-200B)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

IQVIA's first-quarter 2026 results highlight a company successfully transitioning into an AI-driven intelligence powerhouse.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

Despite the headline growth, a closer look at IQVIA's margins reveals a troubling trend of selling growth at a discount. The cost of revenues jumped 10.5% to $2.796 billion, outpacing revenue growth and increasing its share of sales to 67.4%.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every IQV filing.

Start Free Trial

Synthesis (Verdict & Resolution)

The Q1 2026 filing presents a tension between robust top-line growth and deteriorating cost structures. While the 8.4% revenue increase and the strategic pivot toward AI-powered commercial solutions provide a bullish narrative of modernization and market leadership, the underlying data shows a struggle to maintain gross margins. The company is successfully growing its footprint, but the cost of that growth is weighing heavily on the bottom line, as evidenced by the rising cost-of-revenue ratio. For investors, the critical pivot point is the balance between the massive R&D backlog and the company's debt service obligations. The aggressive share repurchase program signals management's confidence, but it also tightens the liquidity cushion at a time when interest expenses are climbing. The overall impact of the filing suggests a company in a high-stakes transition: if IQVIA can successfully convert its backlog and realize the efficiencies of its new segment structure, the long-term upside is significant. However, the current reliance on leverage to fund buybacks amidst margin compression introduces a level of risk that cannot be ignored.

Selected Quarter

Core Takeaway

IQVIA is successfully growing its AI-driven commercial business, but the cost to acquire and deliver that growth is eroding gross margins.

Investor Lens

The trade-off is between aggressive shareholder returns (buybacks) and the need to deleverage and protect margins.

Watch Next

The conversion rate of the R&D backlog into actual revenue in the next two quarters.

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)+0.23Q2 '26 (10-Q)

Signal Timeline

Active Filters:Quarter: Q2 '26 (10-Q)
bullishMay 5

Revenue grew 8.4% to $4.15B with strong growth in Commercial Solutions.

earnings beat
70%
bearishMay 5

Cost of revenues increased 10.5%, outpacing revenue growth and compressing gross margins.

margin compression
60%
bullishMay 5

Aggressive share repurchases totaling $552 million in the first quarter.

buyback
80%
neutralMay 5

Issued $650 million Term Loan to repay maturing Euro-denominated notes.

debt restructure
40%
bullishMay 5

Revenue grew 8.4% to $4.15B with strong growth in Commercial Solutions.

earnings beat
70%
bearishMay 5

Cost of revenues increased 10.5%, outpacing revenue growth and compressing gross margins.

margin compression
60%
bullishMay 5

Aggressive share repurchases totaling $552 million in the first quarter.

buyback
80%
neutralMay 5

Issued $650 million Term Loan to repay maturing Euro-denominated notes.

debt restructure
40%
bullishMay 5

Revenue grew 8.4% to $4.15B with strong growth in Commercial Solutions.

earnings beat
70%
bearishMay 5

Cost of revenues increased 10.5%, outpacing revenue growth and compressing gross margins.

margin compression
60%
bullishMay 5

Aggressive share repurchases totaling $552 million in the first quarter.

buyback
80%
neutralMay 5

Issued $650 million Term Loan to repay maturing Euro-denominated notes.

debt restructure
40%
bullishMay 5

Revenue grew 8.4% to $4.15B with strong growth in Commercial Solutions.

earnings beat
70%
bearishMay 5

Cost of revenues increased 10.5%, outpacing revenue growth and compressing gross margins.

margin compression
60%
bullishMay 5

Aggressive share repurchases totaling $552 million in the first quarter.

buyback
80%
neutralMay 5

Issued $650 million Term Loan to repay maturing Euro-denominated notes.

debt restructure
40%
bullishMay 5

Revenue grew 8.4% to $4.15B with strong growth in Commercial Solutions.

earnings beat
70%
bearishMay 5

Cost of revenues increased 10.5%, outpacing revenue growth and compressing gross margins.

margin compression
60%
bullishMay 5

Aggressive share repurchases totaling $552 million in the first quarter.

buyback
80%
neutralMay 5

Issued $650 million Term Loan to repay maturing Euro-denominated notes.

debt restructure
40%
bullishMay 5

Revenue grew 8.4% to $4.15B with strong growth in Commercial Solutions.

earnings beat
70%
bearishMay 5

Cost of revenues increased 10.5%, outpacing revenue growth and compressing gross margins.

margin compression
60%
bullishMay 5

Aggressive share repurchases totaling $552 million in the first quarter.

buyback
80%
neutralMay 5

Issued $650 million Term Loan to repay maturing Euro-denominated notes.

debt restructure
40%
bullishMay 5

Revenue grew 8.4% to $4.15B with strong growth in Commercial Solutions.

earnings beat
70%
bearishMay 5

Cost of revenues increased 10.5%, outpacing revenue growth and compressing gross margins.

margin compression
60%
bullishMay 5

Aggressive share repurchases totaling $552 million in the first quarter.

buyback
80%
neutralMay 5

Issued $650 million Term Loan to repay maturing Euro-denominated notes.

debt restructure
40%

Filing History

10-QMay 5, 2026
Expand Sequence

The Q1 2026 filing presents a tension between robust top-line growth and deteriorating cost structures. While the 8.4% revenue increase and the strategic pivot toward AI-powered commercial solutions provide a bullish narrative of modernization and market leadership, the underlying data shows a struggle to maintain gross margins. The company is successfully growing its footprint, but the cost of that growth is weighing heavily on the bottom line, as evidenced by the rising cost-of-revenue ratio. For investors, the critical pivot point is the balance between the massive R&D backlog and the company's debt service obligations. The aggressive share repurchase program signals management's confidence, but it also tightens the liquidity cushion at a time when interest expenses are climbing. The overall impact of the filing suggests a company in a high-stakes transition: if IQVIA can successfully convert its backlog and realize the efficiencies of its new segment structure, the long-term upside is significant. However, the current reliance on leverage to fund buybacks amidst margin compression introduces a level of risk that cannot be ignored.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.